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Abstract 
Spirulina is one of the microalgae containing nutrients used as functional food and in theraupetic (active compound). 
Bioactive compound in Spirulina has antihyperglycemic activity or antidiabetes activity. Diabetes mellitus is a major health 
problem in the world. The research about the potential of microalgae as antihyperglicemic is important to do. The cultivation of 
microalgae was conducted in laboratory using flask and aquarium completed with non-stop aeration. Measurement of the 
antihyperglycemic activity in-vivo using mices that were fed with biomass containing Spirulina fusiformis Voronikhin and 
phycocyanin. Blood glucose levels were measured by methods of oral glucose tolerance test after a fasting period of 18 h.  Oral 
administration of biomass and phycocyanin of Spirulina fusiformis V. at 0.15 mg  · g–1 and 0.30 mg  · g–1   proved to decrease the 
blood glucose level.  
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1. Introduction 
Spirulina is one of the microalgae containing nutrients used as functional food and therapeutic (active 
compound), so that it is good for health. It also has potentiality as hypocholesterol and immunostimulant1. Spirulina 
has therapeutic properties which include prevention and inhibition of cancer, ability to decrease blood cholesterol 
levels, to stimulate the immunological system, and to reduce nefrotoxicity of pharmaceutical and toxic metal2,3. 
Spirulina is used as food supplement and it contains biopigment phycocyanin which has a potential as source of 
nutraceutical and pharmaceutical  substances.  
Blue green alga Spirulina platensis Voronikhin (S. platensis) with a dose of 150 mg · kg–1 body weight can lower 
blood glucose levels up to 33 % of the control condition4, thus, it can be used for diabetes mellitus (DM) therapy. 
DM is a metabolic disorder characterized by chronic hyperglycemia with disturbance of carbohydrate, protein or fat 
metabolism resulting from defects in insulin secretion, insulin action or both. Although several synthetic 
hypoglycemics are developed but a truly safe and effective treatment paradigm has not been developed yet5.  
Several studies have been carried out to find α-glucosidase inhibitors from natural products, including plant 
materials, as alternative hypoglycemic agents for diabetes. The methanol extract of Euonymus alatus inhibited α-
glucosidase activity by 69.4 % up to at concentrations of  0.50 mg ·  mL–1  in vitro6. 
The prevalence DM in Indonesia is ranked number four or around 8.6 % from the total population. Patients with 
type–2 DM require oral hypoglycemic drugs (OHO) since the diet does not  control their blood glucose levels. Using 
OHO cause side–effect  abnormal hypoglycemic6. Traditional medicine have to be proved scientifically. Spirulina is 
a natural products that has potential to overcome hyperglycemic, but still needs more research. One of the natural 
pigment in Spirulina is phycocyanin that has antioxidant activity. Research on antihyperglicemic activity of 
phycocyanin is scarce, thus, further research is needed to determine the benefit of phycocyanin. The presence of 
phycocyanin in Spirulina depends on its growth and harvesting time. There are only few strains of cyanobacter that 
have ability to produce high amount of  phycocyanin. Phycocyanin content in Spirulina can be improved by 
manipulating culture condition. The purposes of the study are to determine the best harvesting time of S. fusiformis 
with the highest phycocyanin level and to test anti hyperglycemic activity of  biomass and phycocyanin of         
S. fusiformis by in–vivo  to evaluate its possible use as an anti–diabetic agent. This study was expected to serve  as 
baseline information for development of Spirulina fusiformis and phycocyanin to become  nutraceuticals and 
pharmaceuticals.   
2. Materials and methods 
Materials used in the study such as Spirulina fusiformis V., was obtained from Indonesia Institute of Science 
(LIPI) Cibinong – West Java, Zarrouk media, male rat aged 6 wk to 8 wk, standar rations feed, sucrose, glucobay 
tablet, mineral water and other chemical for analysis.  The equipment that was used in this study include glass jars, 
aquarium, lux meter, aerator, oven, spectrophotometer, freezer, glucose strip test, centrifuse and others glass ware. 
The study involved culturing of S. fusiformis, harvesting cell, extraction of  phycocyanin, antihyperglicemic activity 
test in vivo. 
2.1 Cultivation of  S. fusiformis and extraction of phycocyanin 
    Cultivation of S. fusiformis was conducted in Zarrouk medium at 28 °C to 30 °C, pH 9 to pH 10, providing the 
lighting 5 500 lux  (1  lux = 1 lm · m–2)  using a tube lamp Phillip 40 W with non–stop aeration.  Sampling of the 
culture was conducted every day for determining of the growth curve based on the optical density (OD), which was 
measured at 480 nm using spectrophotometer.  The scalling up to 100 L was conducted in aquarium with the same 
condition as in  semi-batch culture.  A 10 % to 20 % of  S. fusiformis inoculant was added to media culture. 
The culture was harvested on the initial and at the end of the logarithmic phase, and at the initial and the end of 
the stationary phase for obtaining the biomass. Separation of biomass was done using nylon filter with 20 μm size. 
The nylon filter was put onto the cover of glass, then the culture was poured. Biomass left in the nylon filter was  
rinsed using freshwater and dried by using a fan in a room temperature for 5 h.  The biomass obtained was weighted 
for the next analysis. 
 Iriani Setyaningsih et al. /  Procedia Chemistry  14 ( 2015 )  211 – 215 213
Extraction method of phycocyanin was conducted by using freeze thawing method7. Biomass of  S. fusiformis 
was extracted with distilled water. The biomass was suspended to the distilled water, then  stirred using magnetic 
stirrer and freezed using a National freezer for 48 h. The sample was thawed and centrifuged in a refrigerated 
centrifuge (4 °C) to obtain crude phycocyanin4 as supernatant.  Then phycocyanin was dried by freeze dryer         
(–77 °C). The phycocyanin will be used for next analysis. 
2.2 Antihyperglicemic activity test by in vivo 
An antihyperglycemic activity test was conducted by oral glucose tolerance test (OGTT) to the animal8. Males of 
Sparague–Dawley rats weighing between 180 g to 200 g were purchased at the Veterinary Institute, Bogor. The rats 
were housed individually in plastic cages and placed in a room which the  temperature of 26 °C to 28 °C. The 
animals were given  feed ad libitum with a standar rations during the test. The cages were cleaned  every 3 d.  In this 
study, 30 animals test were divided to six groups including rats which were given acarbose 0.001 mg · g–1 body-
weight (P), rats that were given dried biomass of S. fusiformis 0.15 mg · g–1  (B1), rats that were given dried biomass 
of S. fusiformis 0.30 mg · g–1 (B2), rats that were given phycocyanin 0.15 mg · g–1 (F1), rats that were given 
phycocyanin 0.30 mg · g–1 (F2), and rats that were not given dried biomass and phycocyanin of S. fusiformis (N). 
Each sample was dissolved in 2 mL mineral water.   
Before test, rats fasted for 18 h then they were taken the blood to measure the fasting blood glucose level. 
Acarbose, dried biomass and phycocyanin of S. fusiformis were administered orally to the rats, except for the N 
group.  After 5 h, the rats were administered 1 mL  sucrose 80 % (w/ v), and blood glucose level was measured after 
0 h, 0.5 h, 1 h, and 2 h, by using a glucose meter (One Touch Ultra). 
3. Result and discussion 
3.1 Growth of  S. fusiformis  
S. fusiformis which was cultivated in Zarrouk media had five growth phases including lag phase reached day 0 to 
day 7 culture, logarithmic phase reached on day 8 to day 31 of culture, declined phase reached on day  32 to day 34 
of culture, stationary phase reached on day  35 to day 75 of culture, and death phase starting from day 76 of culture 
(Figure 1). On the lag phase, microalgae cell still adapted to the environment. However, on the logarithmic phase, it 
grew fastly and  produced biochemical compounds. Decrease in the cell density was due to the death cell and lysis. 
The lysis occured due to the difference in the osmotic pressure between the cell and environment.  
 
 
 
Fig. 1. Growth curve of S. fusiformis in Zarrouk medium 
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3.2 Biomass and phycocyanin of S. fusiformis  
The culture age affected the amount of the cell biomass.  Harvesting the culture was conducted on day 8 (initial 
of the logarithmic phase), day 15 (middle of the logarithmic phase), day 31 (end of the logarithmic phase), day 35 
(initial of the stationary phase), and day 75 (end of the stationary phase). The dried biomass cell of the S. fusiformis 
that  were harvested on day 8, day 15, day 31, day 35 and day 75  were 81.4 g, 82.1 g, 110.6 g, 117 g and 123.5 g, 
respectively. The water content  of them were 8.14 %, 8.21 %, 8.46 %, 8.48 %, and 8.77 %, respectively. S. 
fusiformis has green biomass (due to chlorophyll). The biomass S. fusiformis that was harvested on stationary phase 
was used for further analysis.  The highest amount of harvestes biomass was obtained during the stationary phase. 
Biomass was dried by using a fan at 27 °C to 28 °C. Mohammad et al. reported that drying at room temperature can 
maintenance the quality of phycocyanin9.   
3.3  Antihyperglycemic activity of cell biomass and phycocyanin 
Inhibition of α-glucosidase is one of the approaches for controlling the blood glucose level. α-Glucosidase is a 
key enzyme in carbohydrate digestion in the small intestine. Therefore, attention has been given to natural subtances 
that have potential as inhibitors against  α-glucosidase and have a few side–effects6. 
Average blood glucose level of rat at 0.5 h after administration of sucrose and biomass of S. fusiformis increased, 
as well administration of sucrose and phycocyanin from S. fusiformis also increased, but after 2 h it decreased (Table 
1 and Table 2). The increase of the blood glucose level at the N group was longer than in the K, B1 and B2 groups. 
It showed that acarbose and biomass S. fusiformis have ability to inhibit the increase of blood glucose level in rats. 
The decreasing mechanism of blood glucose levels in rats is still  unknown. Pandey et al. reported that diabetic rats 
treated with S. maxima showed increase in body weight which may be explained by an increased  insulin secretion 
or increased food consumption. Oral administration of S. maxima could reverse the diabetic effect10.  
 
Table 1.  Average blood glucose levels of rats given biomass of S. fusiformis 
Treatment 0 h*) 0.5 h*) 1 h*) 2 h*) 
N (sucrose) 72.8 ± 0.837 116.4 ± 2.702 133.8 ± 0.837 107.8 ± 1.643 
K (acarbose 0.001 mg · g–1 + sucrose) 72.6 ± 0.849 84.2 ± 1.095 94.4 ± 0.548 88.4 ± 0.548 
B1 (biomass  0.15 mg · g–1 + sucrose) 73.4 ± 0.548 97.6 ± 0.548 112.8 ± 1.304 80.0 ± 0.707 
B2 (biomass 0.30 mg · g–1 + sucrose) 73.4 ± 0.548 91.8 ± 0.447 99.8 ± 0.447 86.0 ± 1.000 
 Noted : *) value ± s.e. 
 
Table 2. Average blood glucose levels of rats given phycocyanin of S.fusiformis 
Treatment 0 h*) 0.5 h*) 1 h*) 2 h*) 
N (sucrose) 72.8 ± 0.837 116.4 ± 2.702 133.8 ± 0.837 107.8 ± 1.643 
K (acarbose 0.001 mg · g–1  + sucrose) 72.6 ± 0.849 84.2 ± 1.095 94.4 ± 0.548 88.4 ± 0.548 
F1 (phycocyanin 0.15 mg · g–1  + sucrose) 73.4 ± 0.548 98.0 ± 0.548 112.8 ± 1.304 86.4 ± 0.707 
F2 (phycocyanin 0.30 mg · g–1 + sucrose) 73.2 ± 0.588 96.0 ± 0.447 107.8 ± 0.447 84.8 ± 1.000 
 Noted : *) value ± s.e. 
 
Phycocyanin of S. fusiformis has ability to inhibit the increase of the  blood glucose level, but its ability was 
lower when compared to acarbose. This requires more study. The effect of phycocyanin at a dose of 0.30 mg · g–1 
body weight was higher than the dose of 0.15 mg · g–1  body weight. According to Gershwin and Belay11, 
biopigments have potential as an antihyperglycemic agents, such as anthocyanin and phycocyanin.  
The effect of S. maxima at a dose of 15 mg · kg–1 of body weight was significantly higher than the dose of         
5 mg · kg–1 and 10 mg · kg–1 body weight. S. maxima has hypoglycemic effect which helps to control blood glucose 
levels and also increased body weight10. Active compound in Spirulina biomass which is used to antihyperglycemic 
include cromium mineral (Cr)12, fatty acid gamma linoleat13, and flavonoid compound14. Based on qualitative test it 
was found that ethanol extract of S. fusiformis containt flavonoids, which have the antihyperglycemic activity.  
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The administration of sucrose to oral glucose tolerance test  raises blood glucose in 60 min15. In this study, blood 
glucose level  in rats increased in 0.5 h after administration of sucrose and the highest  level occurred after 1 h   
Average blood glucose level increased from 72.8 mg · dL–1  to 133.8 mg · dL–1.  Mridha et al reported that digestion 
of sucrose (carbohydrate) occures in the  small intestine giving glucose and fructose4. The biomass and phycocyanin 
of the S. fusiformis at dose of 0.15 mg · g–1  body weight and 0.30 mg g–1 body weight have effect to control on 
blood glucosa level16. 
4. Conclusion 
S. fusiformis   which was cultivated in Zarrouk media had five growth phases including lag phase reached on day 
0 to day 7 culture, logarithmic phase reached on day 8 to day 31, declined phase reached on day 32 to day 34, 
stationary phase reached on day 35 to day 75, and death phase starting from day 76. The culture age affects the 
amount of the  biomass. The biomass and phycocyanin of the S. fusiformis have ability to inhibit increasing blood 
glucose level in rats.  The effects of biomass and phycocyanin at a dose of 0.30  mg · g–1 body weight was higher 
level than the doses of 0.15 mg · g–1  body weight.  
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